Global shortage of key Covid drug leads to NHS rationing
by Sarah Boseley Health editor from Science | The Guardian on (#58VG2)
Pressure mounts on manufacturer to allow other companies to supply remdesivir
A global shortage of remdesivir, one of the key Covid-19 drugs given to Donald Trump since he tested positive for the virus, is leading to rationing in the UK and pressure on the manufacturer to allow other companies to supply it.
Remdesivir, made by the US company Gilead, is one of only two drugs proven to work against Covid-19. It has been shown to help patients recover faster from the disease and shorten the length of hospital treatment but is not a cure.
Continue reading...